Skip to content

Clinical trials

Completed Phase 1 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Status: Completed Clear all

296 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200013
20014
20028
200312
200410
200511
200615
200715
200813
200920
201010
20115
201213
201312
201411
201511
201615
201715
201811
20198
20209
202113
20222
20235
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed296

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
Memorial Sloan Kettering Cancer Center16
M.D. Anderson Cancer Center9
Novartis Pharmaceuticals7
Roswell Park Cancer Institute7
AstraZeneca6
H. Lee Moffitt Cancer Center and Research Institute5
National Institutes of Health Clinical Center (CC)5
Emory University4
Jonsson Comprehensive Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms296
Carcinoma, Non-Small-Cell Lung157
Breast Neoplasms78
Ovarian Neoplasms57
Neoplasms52
Colorectal Neoplasms51
Pancreatic Neoplasms42
Head and Neck Neoplasms40
Small Cell Lung Carcinoma38
Melanoma35

Trials

Showing 1 to 25 of 296. Each trial links to its page on Pharma Observatory.

196 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.